MedTrace Logo

Lidocaine Infusion or Quadratus Lumborum Block and Intrathecal Morphine, Versus Intrathecal Morphine Alone

NCT03658109 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2021-05-10

No results posted yet for this study

Summary

This study may provide evidence for whether or not systemic lidocaine infusion offers significant advantage over truncal regional blocks in gynecology oncology surgery patients in terms of post-operative analgesia, recovery, and safety profile. Further, it may show whether there is any increased efficacy of adding truncal regional block or systemic lidocaine versus intrathecal opioid administration alone.

Conditions

  • Gynecologic Cancer

Interventions

DRUG

Lidocaine Bolus Infusion

Patients will undergo Lidocaine Bolus infusion.

PROCEDURE

QL block

Patients will undergo a posterior QL block pre-operatively

DRUG

Saline Bolus Infusion

Patients will undergo Saline Bolus infusion.

PROCEDURE

Simulated QL block

Patients will undergo a simulated posterior QL block pre-operatively.

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Prentiss Lawson, MD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-24
Primary Completion
2021-05-04
Completion
2021-05-04
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03658109 on ClinicalTrials.gov